BIVDA's response to relevant legislation issues and key reports from the sector.
The decision to leave the European Union (EU) raised fundamental questions about the environment in which the life sciences sector – including in vitro diagnostics (IVDs) – operates. IVDs range from pregnancy self-tests, to blood-glucose meters, to state-of-the-art analytical laboratory equipment. The UK medical technology industry consists of over 3,000 companies with a combined turnover of £15bn. The UK is the fifth largest market for IVDs in Europe.